Comparison of 3-year Clinical Outcomes After Endovascular Therapy for Aortoiliac Artery Occlusive Disease Between Patients With and Without Hemodialysis: Subanalysis of the Real-AI Registry
from Catheterization and Cardiovascular Interventions via MDLinx
In the cohort of this large-scale, multicenter, retrospective registry study including 574 consecutive patients with aortoiliac (AI) occlusive disease, researchers assessed primary patency, assisted primary patency and secondary patency as well as overall survival and major adverse limb events (MALEs) over three years following endovascular treatment (EVT) for AI occlusive lesions in 57 propensity-matched pairs of patients who did and did not undergo hemodialysis (HD).
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063